FRISCO, Texas, May 11, 2012 /PRNewswire/ -- SomnoMed
(SOM.AX) - expects shipment of its 100,000th SomnoDent® apnea
appliance case since the inception of the company in June 2012. This important company milestone is
anticipated to occur whilst SomnoMed attends the annual Associated
Professional Sleep Societies (APSS) conference in Boston.
"This is a significant milestone for us as it demonstrates
continued strong demand for SomnoDent® sleep apnea treatment," said
Ralf Barschow, President & CEO
of SomnoMed. "With more than 100,000 patients and counting we are
continuing to grow and expand the products and services associated
with SomnoDent sleep apnea treatment."
We look forward to announcing further details associated with
this 100,000 treatment in June.
About SomnoMed
SomnoMed is a public company (SOM.AX) providing diagnostic and
treatment solutions for Sleep Breathing Disorders such as
Obstructive Sleep Apnea. SomnoMed was commercialized on the basis
of extensive clinical research. Supporting independent clinical
research, continuous innovation and instituting medical
manufacturing standards has resulted in SomnoDent® becoming the
state-of-the-art and clinically proven medical oral appliance
therapy for obstructive sleep apnea. For additional information,
visit SomnoMed at www.somnomed.com.
Contact:
Anthony White
+1-972-978-4906
awhite@somnomed.com
SOURCE SomnoMed